Kusajili – Clinical trials directory

Result of your search per sponsor: Breast Cancer Study Group (BOOG) (The Netherlands)

Woman Max 99 years
Breast Cancer Study Group (BOOG) (The Netherlands) Update Il y a 4 ans

Open label, comparative, randomised, multicentre study of trastuzumab given with docetaxel versus sequential single agent therapy with trastuzumab followed by docetaxel as first-line treatment for Her2neu+++ metastatic breast cancer patients Not provided at time of registration

Country None
organs None
Specialty None

Closed trial

More information